{"schema_version":"secwatch.filing_event.v1","accession":"0000719135-23-000066","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2023-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.811933+00:00","generated_at":"2026-06-07T21:15:32.523966+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Apyx Medical appoints Matthew Hill as CFO effective Dec 4, 2023","bullets":["Matthew Hill appointed CFO, effective Dec 4, 2023, succeeding Tara Semb who departed Nov 9.","Hill brings 30+ years experience, previously CFO of PDS Biotech, Strata Skin Sciences, and other healthcare firms.","Employment terms: $425K base salary, $50K sign-on bonus, target bonus ≥50% of base, stock option for 150K shares.","Hill will also serve as Principal Financial Officer and Principal Accounting Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0000719135-23-000066","json":"https://secwatch.observer/filing/0000719135-23-000066.json","markdown":"https://secwatch.observer/filing/0000719135-23-000066.md","text":"https://secwatch.observer/filing/0000719135-23-000066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000066/0000719135-23-000066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000066/apyx-20231121.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T21:15:32.523966+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"69fab90132","claim":"Matthew Hill was appointed as Chief Financial Officer at Apyx Medical Corp.","evidence_excerpt":"On November 28, 2023, Apyx Medical Corporation (the “Company”) announced that it had appointed Matthew Hill as its Chief Financial Officer, effective December 4, 2023 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000066/0000719135-23-000066-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}